Component

GDC-0834

GDC-0834. Species, exposure and limitations are retained in each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Inhibitor and fractionation experiments implicated AO and carboxylesterase, but not XOR, in GDC-0834 amide hydrolysis.

    Human aldehyde oxidase 1 / AOX1 → GDC-0834 source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/molybdenum-research/25845827.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8f5a9632067829ecae57508a9127fb042a6467165c3fc494fdd44be975dadf40", "start_char": 0, "end_char": 1619, "text_sha256": "8f5a9632067829ecae57508a9127fb042a6467165c3fc494fdd44be975dadf40"}
    experimental_model
    Human liver cytosolic fractionation, proteomics, inhibitors and docking
    exposure
    GDC-0834 amide-hydrolysis assays
    limitations
    AO and carboxylesterase both implicated; docking proposes a mechanism but does not prove every catalytic step.
    nutrient_topic
    Molybdenum research collection; topical membership is not evidence of a direct dietary effect. · Molybdenum
    organism
    Homo sapiens
    plain_language
    AOX1 can participate in drug breakdown beyond simple aldehyde oxidation.
    primary_references
    [mo-p25845827] A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834. (2015). https://pubmed.ncbi.nlm.nih.gov/25845827/ DOI: 10.1124/dmd.114.061804
    tissue_or_cell_type
    Liver cytosol

    Molybdenum: cofactor assembly, sulfur metabolism and nutrient interactions (2026-09-17) · lines 924–935

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human liver cytosolic fractionation, proteomics, inhibitors and docking · source_derived_draft · unverified_draft

    ### mo-aox-amide Inhibitor and fractionation experiments implicated AO and carboxylesterase, but not XOR, in GDC-0834 amide hydrolysis. Condition category: normal nutrient_topic: Molybdenum research collection; topical membership is not evidence of a direct dietary effect. plain_language: AOX1 can participate in drug breakdown beyond simple aldehyde oxidation. organism: Homo sapiens tissue_or_cell_type: Liver cytosol experimental_model: Human liver cytosolic fractionation, proteomics, inhibitors and docking limitations: AO and carboxylesterase both implicated; docking proposes a mechanism but does not prove every catalytic step. exposure: GDC-0834 amide-hydrolysis assays evidence_span: {"source_cache": "artifacts/molybdenum-research/25845827.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8f5a9632067829ecae57508a9127fb042a6467165c3fc494fdd44be975dadf40", "start_char": 0, "end_char": 1619, "text_sha256": "8f5a9632067829ecae57508a9127fb042a6467165c3fc494fdd44be975dadf40"} [mo-p25845827] A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834. (2015). https://pubmed.ncbi.nlm.nih.gov/25845827/ DOI: 10.1124/dmd.114.061804
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards